![]() 72% were prescribed metoprolol succinate the seventh most prescribed medicine in New Zealand. ![]() In 2016, 325 000 people received a beta-blocker from a community pharmacy in New Zealand: 1 Metoprolol succinate is the most frequently prescribed beta-blocker in New Zealand Preferred for patients with co-existing chronic obstructive pulmonary disorder (COPD) because they cause less bronchoconstriction That are less likely to cause fatigue and cold extremities than non-specific beta-blockers and are often Bisoprolol is an alternative to metoprolol succinate in many cases both are once-daily cardioselective beta-blockers.From 6-12 months onwards post-myocardial infarction, consider withdrawing beta-blockers for patients without heartįailure or arrhythmias, if re-vascularisation has occurred.Should also be withdrawn slowly, ideally over several months, to prevent rebound symptoms such as resting When a beta-blocker is initiated, a slow upwards titration of dose is recommended to minimise adverse effects.With the presence of co-morbidities, to individualise care for patients with cardiovascular conditions Beta-blockers are a diverse group of medicines and prescribers should consider their different properties, along. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |